JCR Pharmaceuticals Co., Ltd. (TYO:4552)

JCR Pharmaceuticals Revenue

JCR Pharmaceuticals had revenue of 9.99B JPY in the quarter ending September 30, 2026, a decrease of -21.93%. This brings the company's total for the last twelve months to 38.93B, up 3.05% year-over-year. In the fiscal year ending March 31, 2026, JCR Pharmaceuticals had annual revenue of 40.32B with 21.91% growth. That makes JCR Pharmaceuticals the 16,045th largest company in the world by revenue and 1,733rd in Japan.

• Revenue (ttm): 38.93B
• Revenue Growth: +3.05%
• P/S Ratio: 1.57
• Revenue / Employee: 39.52M
• Employees: 985
• Market Cap: 61.00B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	40.32B	7.25B	21.91%
Mar 31, 2025	33.07B	-9.80B	-22.86%
Mar 31, 2024	42.87B	8.53B	24.83%
Mar 31, 2023	34.34B	-16.74B	-32.77%
Mar 31, 2022	51.08B	21.00B	69.79%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error